TORS ‘viable’ and preserves QoL in oropharyngeal cancer
Patients with oropharyngeal squamous cell carcinoma who are treated with transoral robotic surgery maintain a high quality of life at 1-year post-surgery, a prospective study indicates (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - August 21, 2013 Category: Cancer & Oncology Source Type: news
Incidence of HPV-Related Oropharyngeal Cancer on the Rise in Canada
Researchers in Canada have shown for the first time that the incidence of HPV-related oropharyngeal cancers is increasing among the Canadian population. (Source: Cancer Network)
Source: Cancer Network - August 21, 2013 Category: Cancer & Oncology Source Type: news
Poor oral health linked to cancer-causing oral HPV infection
(American Association for Cancer Research) Poor oral health, including gum disease and dental problems, was found to be associated with oral human papillomavirus infection, which causes about 40 percent to 80 percent of oropharyngeal cancers, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 21, 2013 Category: Cancer & Oncology Source Type: news
Promising Biomarker for HPV-Related Oropharyngeal Cancer
More than one-third of patients with oropharyngeal cancer were seropositive for HPV16 E6 an average of 6 years prior to their cancer diagnosis compared with less than 1% of healthy controls, a new study has found. (Source: Cancer Network)
Source: Cancer Network - July 23, 2013 Category: Cancer & Oncology Source Type: news
HPV virus raises throat cancer risk
Infection with certain types of the HPV virus significantly increases the risk of oropharyngeal cancers - cancers in the back of the throat - according to a new study. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - July 22, 2013 Category: Nursing Source Type: news
HPV linked to a third of throat cancers
One third of people with cancers in the back of the throat (oropharyngeal cancers) are infected with a certain strain of human papillomavirus (HPV), according to new research published in the Journal of Clinical Oncology at the weekend. The research team, which included Cancer Research UK scientists at the University of Oxford, compared pre-diagnostic blood samples from 938 patients with cancers of the head and neck, oesophageal (gullet) and oropharyngeal cancers with samples from 1,599 people without the disease (the controls)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 22, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Epidemic of HPV Oropharyngeal Cancer, But Why?Epidemic of HPV Oropharyngeal Cancer, But Why?
There has been a dramatic increase in oropharyngeal cancer associated with human papillomavirus type 16, but it is not clear why. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 2, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Blood Test May Detect Sexually Transmitted Throat Cancer
A blood test can detect antibodies of HPV that can cause throat and oral cancers years before the symptoms of the disease become apparent, researchers from the National Cancer Institute and the International Agency for Research on Cancer reported in the Journal of Clinical Oncology. In the study, close to 1 in 3 people with oropharyngeal cancer had antibodies to HPV (human papilloma virus), compared with fewer than 1 in 100 without cancer. When present, these antibodies could be found several years before onset of the disease... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 18, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news
Nanobiotix receives approval from ANSM
NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, has announced that its lead compound NBTXR3 has received authorisation from the French Medicine Agency, ANSM,(1) to start a clinical trial in patients with locally advanced cancers of the oral cavity or oropharynx (head and neck cancer), at the Institut Curie, Paris, France, a French leading cancer treatment centre. This represents a second indication for NBTXR3 which is also in clinical trials for soft tissue sarcoma. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 17, 2013 Category: Drugs & Pharmacology Source Type: news
NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer
(NIH/National Cancer Institute) Researchers have found that antibodies against the human papillomavirus may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 17, 2013 Category: Global & Universal Source Type: news
Can Oral Sex Cause Throat Cancer?
Michael Douglas was diagnosed with throat cancer (oropharyngeal cancer) three years ago. He initially said it was caused by years of heavy smoking, alcohol abuse and stress. However, he recently told The Guardian newspaper that it was caused by oral sex (cunnilingus). In an Interview with Guardian reporter, Xan Brooks, Douglas said that his type of cancer was caused by the human papillomavirus (HPV) "which actually comes from cunnilingus"... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 4, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news
Seeking A Less Toxic Radiation Treatment For HPV-Positive Oropharynx Cancer
Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings were presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news
Michael Douglas: oral sex caused my cancer
Actor reveals to the Guardian that HPV, transmitted through oral sex, was responsible for his throat cancerXan Brooks' full interview: Michael Douglas on Liberace, Cannes, cancer and cunnilingusJames Ball: is Douglas right about cunnilingus cancer link?Michael Douglas – the star of Basic Instinct and Fatal Attraction – has revealed that his throat cancer was apparently caused by performing oral sex.In a surprisingly frank interview with the Guardian, the actor, now winning plaudits in the Liberace biopic Behind the Candelabra, explained the background to a condition that was thought to be nearly fatal when diagnosed th...
Source: Guardian Unlimited Science - June 2, 2013 Category: Science Authors: Catherine Shoard Tags: United States World news Health guardian.co.uk Cancer Film Michael Douglas Source Type: news
ASCO: HPV-Oral Cancer Won't Threaten Spouses
CHICAGO (MedPage Today) -- Oropharyngeal cancers that arise from human papillomavirus (HPV) don't appear to put domestic partners at elevated risk of either the infection or the same cancer, an observational pilot study showed. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 1, 2013 Category: Hematology Source Type: news
Researchers investigate a less toxic radiation treatment for HPV-Positive oropharynx cancer
(Fox Chase Cancer Center) Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 30, 2013 Category: Global & Universal Source Type: news
